This review highlights the complex, multifactorial mechanisms—including volume overload, hypertension, anemia, and vascular access flow—that drive the high incidence of congestive heart failure in ESRD patients on chronic hemodialysis.
Answers are grounded in this paper and cite their sources.
Supports holistic evaluation of heart failure in dialysis patients; leaves open mechanism-specific intervention trials.
More than 50 % of end-stage renal disease (ESRD) patients treated by chronic hemodialysis die from cardiovascular diseases, including congestive heart failure (CHF). The incidence of CHF is rising in both general and ESRD population. However, the mechanisms, which lead to the development of CHF in dialyzed patients, differ considerably. First, there are several factors leading to increase of the left ventricular afterload: volume overload between dialyses, hypertension, increased arterial stiffness, anemia, vascular access flow (arteriovenous fistula) and sympathetic activation. Second, hypertension, left ventricular hypertrophy, anemia and frequently present coronary artery disease worsen myocardial oxygenation. The combination of these factors explains the high incidence of CHF in dialyzed patients and their roles are reviewed in this article.
No takes yet. Share an insight, caveat, or question.
Malík et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: